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Introduct ion

I am going to speak mainly
about extracorporeal hemodialysis,
that is, dialysis conducted with an
artificial kidney as opposed to peritoneal dialysis. I am going to direct
the majority of my comments toward the extraordinary technique
of the maintenance of life in patients with chronic renal failure. I
would like to break my discussion
into three general areas: 1) a review of the historical development
of the dialyzer, including some remarks on what happens at the
membrane level; 2) a look at the
results we are getting with this
kind of hardware ; and 3) a comment on some of the newer experimental dialyzers.
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Fig. I- Blood hemodialyzer reported by Abel in 1913.

H isto rical Development

Figure
shows a dialyzer
credited to Abel in 1913. This is a
rather ingenious device for all its
simplicity. It is a collection of collodion tubes, marked ( C), contained in a cylinder of glass. Blood
flowed through the collodion tubes
and dialysis fluid through the cylinder surrounding them. This was the
first successful extracorporeal hemodialyzer on record.
Figure 2 illustrates a device that
is probably the most famous of
the artificial kidneys. This was designed by Dr. Willem Kolff in Holland in 1943, 30 years after Abel's
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Fig. 2-The Kcltf-Merrill rotating drum dialyzer.
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first attempt. It consisted of a drum
on which blood-filled tubes of cellophane were wrapped. This tubular cellophane was of the garden
variety, food-wrapping sort. The
loops were strung over a drum of
stainless steel. Dr. Kolff's original, I
understand, was made from wooden
bed slats and a variety of other
makeshift gear that he assembled.
This was translated by Dr. Merrill
and himself at the Peter Bent
Brigham Hospital into the gleaming stainless steel and p!exiglass
item you see in the figure. The
blood leaves the radial artery of the
patient. It is taken to the beginning
of this helically wound spiral of
cellophane. Movement of blood
through the spiral is accomplished
by the Archimedes screw principle.
Eventually the blood is returned,
after passing through a bubble trap,
into a vein in the patient's arm.
The dialysis fluid is in the trough
underneath the drum. The drum
rotates with its lower third submerged in the dialysate and wets
the membrane.
What happens at the membrane
level? Figure 3 is a diagrammatic
sketch of a cellophane membrane .
The white circles represent large
molecular-weight solutes, such as
protein and the cellular elements,
which are retained because they
are too large to traverse the membrane. The smaller dark particles,
of course, move easily through the
pores of the membrane and are
trapped in the dialysis fluid. The
driving force is diffusion. Dialysis
is, in essence, diffusion across a
membrane, and is a simple matter
of discharging gradients. The toxic
solutes, e.g., urea, that are present
in the blood in high concentration,
are absent in the dialysis fluid and,
therefore, move so as to discharge
this concentration difference. The
solutes that are small in molecular
weight, and are desirable to retain
in the blood, such as, possibly, sodium, can be placed in the dialysis
fluid in physiologic concentrations.
As a result of diffusion, abnormalities of serum sodium would

asymptotically approach the normal
value of the sodium in the dialysis
fluid. Dialysis is a great normalizer.
Figure 4 is a photomicrograph
of cellophane. You can see that the
pores are less orderly. It looks like
a haystack run over by a steam
roller. The success of cellophane as
a dialysis membrane was an empirical triumph. The selection of the
membrane was an arbitrary one.
Dr. Kolff used this, and it has been
used ever since. There have been
strong efforts to find better ones,
but cellulosic membranes are still

the most widely used item for dialysis.
Just to give you a comparison
with our divine prototype, in Figure
5 you see on the left the artificial
kidney membrane. Cuprophan is
one of the best of the cellulosic
dialysis membranes. On the right is
the glomerular basement membrane. An axiom in dialysis is that
the shorter the diffusion path, the
more efficiently you can move solutes. If you had your option, you
would take the thinnest dialysis
membrane available that could to!-

Fig. 3-Diagrammatic representation of cellophane membrane. The light gray
area represents the blood path; the dark gray area represents dialyzing fluid. The
blood path is bounded by cellophane membranes with diagrammatic pores permitting the loss of small solutes (represented as black squares). Macromolecular
structures and cellular elements in blood are represented by white circles.
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erate the pressure gradient without
rupturing. As you can see, we are
still far from the natural membrane.
To move back to the historical
side, the next development came
when a young surgeon in Philadelphia named William Inouye decided that the large, rotating drum
dialyzer which is, to put it in perspective, like a small sarcophagus,
could be reduced in size, and that
this would be an advantage. He
wrapped the cellophane tubing up
so that it was now a tightly wound
spiral separated by a supporting
screen. This membrane package fit
neatly into an old pressure cooker.
Dialysis fluid was then percolated
up through the screen. This was
later to develop into the twin-coil
kidney. Dr. Inouye reported this
modification in 1953. Dr. Kolff improved the design and in 1955
came out with his first twin-coil
kidney. The circuitry for the twincoil is presented in Figure 6 and
is relatively straightforward. Blood
leaves the artery, moves through
a blood pump, and goes to the cellophane coil in the inner bucket.
Dialysis fluid is pumped over the
cellophane membrane, where diffusion occurs. The blood then returns to bubble traps and is returned to the vein.
There are a variety of artificial
kidneys that have been developed
since the original rotating drum
and the development of the twincoil kidney. The parallel flow plate
dialyzers, such as the SkeggsLeonards and the Kiil, came along
after the development of the rotating drum. The next significant
development had to do with the
deliberate attention paid by Dr.
B. H . Scribner in 1960 to the problem of what could be done with the
patient in chronic renal failure. Up
until then, such devices had been
successfully applied to patients with
acute renal failure, but that was
all. In 1964, W. Quinton reported
a device for ready access to the
blood vessels of the patient. Clearly,
the limiting feature of repeated
150

Fig. 4-Electron micrograph of cellophane.
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Fig. 5-A comparison of Cuprophan and glomerular basement membrane.
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dialysis had to do with access to
blood vessels. These vessels had to
be cut down on surgically and tied
off after the procedure. This could
be carried out relatively few
times. Mr. Quinton addressed himself to the design of a shunt, and
Dr. Scribner applied this to the
care of patients with chronic renal
failure . In Figure 7 we see such a
shunt implanted in the forearm.
The radial artery is used, and blood
returns to the vein running out of
the "snuffbox" on the forearm. The
loop on the left can be removed,
and this, then, provides access to
artery and vein. The kidney leads
are attached to the shunt. This has
worked exceptionally well. Shunts
have been left indwelling on single
placement without change for as

long as a year. The problem that
can arise is infection, usually staphylococcal. Such an infection may
result in septicemia. More frequently the shunt clots, so you lose
your shunt site and have to reimplant higher in the same vessel or
in a different area.
In 1964, a variety of workers
began to experiment with simplifying dialysis technique to the point
where it could be carried out in the
home. Drs. Merrill in Boston, Shaldon in England, and Scribner on
the West Coast all became interested in home dialysis. They saw
in this a technique that was more
economical in that the costs incurred for bed charges in a hospital, nursing personnel, etc., could
be eliminated. Home dialysis, then,

and placement of the shunt in the
leg rather than the arm, so that the
patient could put himself on the
kidney, was the next major development.
In 1966 Dr. M. J. Brescia, going
a step beyond Scribner ( 1965) ,
created an arteriovenous fistula of
the vessels that are usually used for
the placement of the shunt and, in
that way, created a hypertrophied
venous tree that could be negotiated with a percutaneous stick
using large gauge needles. There
are cosmetic benefits as well as the
likelihood that the incidence of infection would be reduced and,
hence, the incidence of clotting.
This has proved to be the case in the
trials that have been carried out so
far .. We have had several patients
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Fig. 6-Circuitry of the Travenol coil artificial kidney.
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with this particular form of
fistula. We have had one patient in
particular, a lawyer, who has used
both of these techniques. He
started with the traditional Quinton arteriovenous shunt and moved
on to the Brescia fistula. He thinks
that, even though it means the pain
of a percutaneous stick every time,
the latter is by far the method he
prefers.
Results
So much for the technique and
equipment. I'd like to focus for a
moment on what may be more controversial, namely, the results of all
of this. I think that there are a
number of parameters that have to
be looked at fairly closely before
assessing whether this technique is
a success or a failure. One guide
that is of quite evident importance
is the survival rate. Survival figures
seem to be quite good, according to
the September, 1967 "Report of
the Committee on Chronic Kidney
Disease" submitted to the Bureau
of the Budget.* Of 302 patients followed for up to seven years, survival
is 87% at one year, 67 % at three
years, and 58 % at seven years. The
number of patients clearly is small ,
and these figures may change as
more patients are added. The cases
that are reported at the seven-year
mark with 58% survival represent
three of the original cases studied by
Scribner in 1960. This figure may
change radically as we see larger
numbers of patients moving through
this technique. As far as mortality
goes, if we can guarantee seven
more years of life for 60 % of the
people who invest their time, I
think this is a handsome success.
Clearly there are other parameters that have to be looked at,
not the least of which is the quality
of life maintained. Is this the simple preservation of a hopelessly
sick person who is not back in the
community, or is there real reha"Prepared by a committee of which
Dr. C. W. Gottschalk was Chairman.
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bilitation? In trying to make this
assessment, which is an exceptionally difficult one, it is important to
ask first, "What does the patient
have to invest?" and second, "Is the
investment worthwhile?"
To any of you who have
had close association with
chronic dialysis, it is clearly
recognized that this is not a
simple technique for the patient
to undergo. He has to be prepared
to put up with a great deal to survive. This is a technique for people who are intelligent and capable,
and if they are not both, as well as
conscientious about caring for themselves, they quickly die. Two to
three times a week they have to invest six to twelve hours on an artificial kidney. If this is done in a
kidney center during traditional
working hours, this cuts into their
day as productive citizens, unless,
of course, they are employed in
some unusual occupation that permits work at night. Many centers
have solved this by providing nighttime dialysis. In home dialysis,
hopefully the patient puts himself on
the machine at 8: 00 in the evening,
sleeps quietly through the night,

and awakens in the morning to take
himself off the kidney. But, nonetheless, this is a significant investment of time. In addition, you are
asking your patient to rigorously
restrict his fluid intake. In the face
of ongoing thirst, this can be exceptionally difficult. Every drop of
fluid taken in excess of, say, a
300-400 cc insensible loss per day
(most of these patients do not
make a significant quantity of
urine), has to be taken out with the
artificial kidney. You ask your patients to hold down their intake to
500-800 cc of fluid per day, even
though they are thirsty. Protein is
restricted; potassium is restricted;
sodium is restricted; so that attention to diet is probably the most
onerous requirement you are asking these patients to fulfill . Your
patient investment here is substantial.
It is quite clear from what I say
that it is imperative to select the patient from the standpoint of reliability and emotional stability. A
staunch psyche is almost prerequisite. In addition, it is important
to have strong family support for
patient and procedure. So the pa-

Fig. 7-Quinton-Scribner arteriovencus sh unt. Sta inl ess steel stabilizers.
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tient and family investment is substantial.
What do they get for their investment? Can these people be rehabilitated? Are they back on the firing
line? Could they go out and dig a
ditch for a living? In general, they
cannot. This is a near-normal but
not a normal state. The fatigue
level of a patient on chronic dialysis is still substantially below normal.
There are ongoing complications that can occur in spite of
good dialysis, one of which is neuropathy. Progressive neuropathy of
the peripheral sort can provide
crippling incapability of the lower
extremities. This can rapidly progress even in the face of "adequate" dialysis. The details of why
this occurs have yet to be worked
out.
Pruritus can be very persistent
in some chronic dialysis patients.
I was amused when Dr. Setter took
me over to view the dialysis unit
here at the Medical College of Virginia to see one of the small Chinese carved hand backscratchers lying on the overbed table of one of
the chronic dialysis patients. This
reminded me of the motto that the
medical residents rotating through
our service have pasted with adhesive tape over our dialyzer-"Semper pruritus." Excoriation of the
skin with subsequent infection in a
patient who does not fight infection
well can provide a serious problem.
Anemia is another problem.
It is evident that when kidneys are
seriously diseased, erythropoietin is
present at unmeasurably low levels
in the blood; there may be a hemolytic component as well. In addition, the bone marrow does not
make red cells normally so that
even with good substantial dialysis,
these patients do carry a low hemoglobin, usually around 8 gm/ 100
cc. This may contribute to the fatigue syndrome of the chronic uremic.
Patient rehabilitation is hard to
assess. Reports vary enormously de-

pending on whom you read. Most
report a reasonable rehabilitation
rate (Brown et al., 1962; Gonzalez
et al., 1963; Kretchmar et al., 1963;
Maher, Freeman and Schreiner,
1965; Rubini, Wolfram and Sokal,
1966; Comty et al., 1966) . There
are few ditch diggers reported that
have done well. You can read the
experiences of others, such as
Retan, in Detroit, where rehabilitation has been very bad. A lot of
the success or failure has to do with
the vigor that the investigator or the
physician applies to motivate his
patients. There is almost a religious
atmosphere to the attitudes of the
patients trained in the Seattle centers. Dialysis is treated as an end
in itself. This becomes a difficult
religion to instigate in a patient if
there are other programs at the institution which may have a higher
priority. This has been difficult for
us in our unit with transplantation
and chronic dialysis both ongoing.
Rehabilitation, then, is a complex
function of patient, institution, and
professional staff.
Let us move on to another
parameter of success. How are we
doing numerically? Are we getting
ahead? There are a variety of figures given. The most solid come
from the "Report of the Committee on Chronic Kidney Disease."
Thirty-five thousand patients per
year die of chronic renal failure.
Of that group, there are some
7,000 per year who would be good
candidates for either dialysis or
transplantation. In the last three
years there has been an enormous input of effort and money
for the setting up of chronic dialysis programs throughout the
United States. The USPHS has
given grants to establish dialysis
units on a trial basis, the Veterans
Administration Hospitals have set
up a string of hemodialysis units
associated with their hospitals, and
most university hospitals now have
such facilities. All in all, there has
been a burgeoning of the hemodialysis effort. How many patients
of these 7,000 per year are now on

the machines? At this moment, approximately 800. The rather ridiculous logistics of the present situation are apparent. If we are receiving 7,000 patients for care each
year, and at the present state of
the art are saving only 800, something clearly needs changing.
Moving on to another rather
sticky wicket, how about th:: monetary end? According to the "Report
of the Committee on Chronic Kidney Disease," in-patient chronic dialysis costs, on the average, $14,000
per year per patient. The most economical way to arrange chronic
dialysis is at home, but this still
costs $5,000 per year, after an initial outlay of about $10,000 for
equipment and supplies. This cost
of home dialysis in most situations
is borne by the patient. Quite
clearly, this introduces a selection
process into the patient population
for chronic dialysis that I am not
sure would meet with the best
standards of a democratic society.
When you realize that an in-patient
chronic dialysis slot lasts for at
least seven years, if you are doing
your job properly, with the annual
cost being as high as it is, it is no
wonder that most insurance underwriters and hospital administrators
blanch when chronic dialysis is proposed. The lives saved-per dollar
spent ratio with chronic dialysis
leaves a good deal to be desired.
Clearly I feel that this is a dramatic lifesaving technique that the
medical profession should be proud
to have. It should be broadly available, but in order to make it so
there have to be some improvements. One of the improvements is
that of cost. Along this line, there
was an interesting parenthetical
comment injected by a member of
the Tokyo Society for Artificial Internal Organs at the 1967 meeting of the American Society for
Artificial Internal Organs. This
gentleman stood up and said, "Beware of the Japar:cse invasion.
We are importing cellophane and
fiberglass screens and making coils
that we will send to the LTnited
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States," at a cost, as I recollect, of
about $20. This, taken in perspective of the $70 fee that the coil he
was describing was then selling for
on the American market, shows one
important area of improvement that
will come along.

New Designs

There are a number of things on
the drawing board for the future
that I think bear close attention.
Moving to one approach in the
new design category, Figure 8, with
all apologies to Chester Gould and
Dick Tracy, was drawn by my colleague, Dr. L. W. Bluemle, and depicts an imaginary miniature dialyzer. It exemplifies one approach to
design. This would be to dtvelop a
small, wearable, continuously dialyzing system. I think you can project this dream to say that the patient straps a tank of dialysis fluid
around his waist in belt fashion and
is good for the day. Miniaturization
is one approach that the innovators
in artificial kidney design have
taken. There are two examples of
this approach that I would like to
show you. One (Fig. 9) is a socalled accordion, push-pull, or tidal
flow dialyzer. It is nothing more
than an accordion folding of sheet
cellophane into a package that
would fit neatly in the palm of your
hand. This particular configuration
permits enormous membrane area
to be put in a small package, and, by
an appropriate valving mechanism,
this rather small membrane package
can be used for dialyzing. This
was the brainchild of Dr. Bluemle.
There are now at least two groups
working with this concept.
Another particularly ingenious
approach to the problem is the spinning of cellophane capillary fibers.
These are hairlike tubes that are
made of cellophane. Again, tremendous membrane area can be
packed into a very small place.
Another approach to the design
problem is to come up with a high
efficiency dialyzer in order to cut
154

dialysis time to an absolute minimum. Under improved efficiency
can come such developments as better membranes and better membrane supports.
A particular approach to a higher
efficiency unit has been worked on
in our laboratory by Dr. Bluemle
and me. Figure 10 at first glance
looks rather complicated. It is a device that employs ultrafiltration, not
diffusion, as its means for cleansing blood. Diffusion is inherently a

slow process. It would be nice to be
able to apply some extrinsic force
to move toxic solutes out of the
body, and we are attempting to use
ultrafiltration pressure as just such
a force. The figure shows a cross
section of such a diafilter, and the
inset illustrates the central blood
path. In addition, there are two
other paths, one on either side of
the blood path. The first is under
positive pressure (10 PSI), forcing
fluid through an ultrafiltration

Fig. 8-Theoretical wearable artificial kidney.

Fig. 9-The Bluemle accordion dialyzer membrane pack.
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Fig. IO-Diagrammatic sketch of the blood ultrafilter.

membrane into the blood; the second, on the other side of the blood
path is under negative pressure,
drawing the fluid right across the
flowing blood stream, carrying with
it all solutes that have traversed the
ultrafiltration membrane. The success of such a device depends on
these two membranes and their
properties. The glomerular basement membrane, after all, does this
sort of thing very nicely. The glomerulus is not a dialysis membrane;
it is an ultrafiltration membrane
and, as such, has a very high efficiency. The present design is an attempt to match this efficiency by
using simultaneous ultrafiltration
and reconstitution of blood. We
have suitable ultrafiltration membranes available to us now, and I
am sure we are going to see developments of this sort as another important step in increasing efficiency.
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